Nu Skin EnterprisesvsThermo Fisher Scientific

NUS and TMO stock compared: price, dividend, valuation and results, from SEC filings.

NUS

Nu Skin Enterprises, Inc.

$4.03

Value $194M

+0.50%
NUS's page

TMO

Thermo Fisher Scientific Inc

$700.22

Value $260B

+0.11%
TMO's page

Nu Skin Enterprises (NUS) has a market value of $194M and Thermo Fisher Scientific (TMO) $260B. Over the last year, with dividends, NUS moved -56.5% and TMO +19.5%. Dividend yield: NUS 5.99%, TMO 0.26%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    NUS$194M

    TMO$260B

    TMO is 1,341 times NUS

  • Revenue, 12 months

    NUS$1.3B

    TMO$47.4B

    TMO is 36 times NUS

  • Net income, 12 months

    NUS-$234M

    TMO$7.1B

  • Operating margin

    NUS-2.0%

    TMO17.9%

    19.9 points apart

  • ROIC

    NUS-2.3%

    TMO8.2%

    10.5 points apart

  • P/E

    NUS–

    TMO36.8

  • Dividend yield

    NUS6.0%

    TMO0.3%

    5.7 points apart

  • 5-year return

    NUS-89.4%

    TMO+11.8%

    101.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

NUS-89.4%

TMO+11.8%

5010020222023202420252026
Returns by period
PeriodNUSWith dividendsTMOWith dividends
1 year since November 12, 2025-56.5%Price -58.0%+19.5%Price +19.1%
3 years since November 13, 2023-72.7%-35.1% a yearPrice -75.3%+58.8%+16.7% a yearPrice +57.3%
5 years since November 12, 2021-89.4%-36.2% a yearPrice -91.2%+11.8%+2.3% a yearPrice +10.2%
10 years since November 15, 2016-89.6%-20.3% a yearPrice -92.5%+384.5%+17.1% a yearPrice +371.0%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

NUSNu Skin EnterprisesTMOThermo Fisher Scientific

Valuation

NUSTMO
Valuation
Price$4.03$700.22
Market value$194M$260B
Enterprise value (EV)$239M$295B
P/E–36.8
P/E, 5-year median17.732.7
P/B0.44.8
EV/EBIT–34.9
Free cash flow yield–2.9%

Results and growth

NUSTMO
Results and growth
Revenue, 12 months$1.3B$47.4B
Net income, 12 months-$234M$7.1B
Free cash flow, 12 months-$26M$7.6B
Earnings per share, 12 months-$4.85$18.96
Revenue growth, year on year-14.3%3.9%
Revenue growth a year, past-10.5%over 5 years+6.7%over 5 years
EPS growth a year, past-2.6%over 5 years+2.1%over 5 years

Margins and returns on capital

NUSTMO
Margins and returns on capital
Gross margin67.8%–
Operating margin-2.0%17.9%
Net margin-17.7%14.9%
ROIC-2.3%8.2%
ROE-33.6%13.4%

Balance sheet

NUSTMO
Balance sheet
Cash$167M$6.1B
Total debt$277M$41.4B
Net debt / EBITDA1.83.7
Interest cover-1.8×5.5×

Dividends and buybacks

NUSTMO
Dividends and buybacks
Dividend yield6.0%0.3%
Dividend per share, 12 months$0.24$1.84
Dividend growth a year, past–+14.3%over 5 years
Buyback yield10.3%1.2%
Shareholder yield16.3%1.4%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: NUS or TMO

Didn't find what you were looking for?

Ask us
Which is bigger, Nu Skin Enterprises or Thermo Fisher Scientific?

By market value, Thermo Fisher Scientific ($260B) is about 1,341.2 times Nu Skin Enterprises ($194M), at today's prices.

How did NUS and TMO stock do over the last 10 years?

Since November 15, 2016, NUS's price moved -92.5% and TMO's +371.0%. With dividends: NUS -89.6% (-20.3% a year), TMO +384.5% (+17.1% a year). Past returns do not predict future ones.

Which pays the higher dividend, NUS or TMO?

The dividend yield at today's price is 5.99% for Nu Skin Enterprises and 0.26% for Thermo Fisher Scientific. Over the last twelve months they paid $0.24 and $1.84 per share.

Which has the higher profit margins, Nu Skin Enterprises or Thermo Fisher Scientific?

Over the last twelve months, the net margin was -17.7% for Nu Skin Enterprises and 14.9% for Thermo Fisher Scientific, and the operating margin -2.0% and 17.9%. Revenue was $1.3B and $47.4B.

Which is the better investment, Nu Skin Enterprises or Thermo Fisher Scientific?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.